| Aktie | Ticker | Breite | GCS | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 19.720.162 $ | +8.505.496 $ | +47,3 % | 3 | 11.214.666 $ | +5.480.955 $ | +81,4 % | 3 | ||||
| Babcock & Wilcox Enterprises, Inc. | BW | → 0 | Sehr schwach | 15.318.708 $ | +8.311.728 $ | +118,6 % | 1 | 7.006.980 $ | +4.682.354 $ | +201,4 % | 1 |
| ADC Therapeutics SA | ADCT | → 0 | Schwach | 2.410.983 $ | -321.009 $ | -11,7 % | 1 | 2.731.992 $ | +901.557 $ | +49,3 % | 1 |
| Cibus, Inc. | CBUS | → 0 | Schwach | 1.990.471 $ | +514.777 $ | +34,9 % | 1 | 1.475.694 $ | -102.956 $ | -6,5 % | 1 |
| 19.720.162 $ | +8.505.496 $ | +47,3 % | 3 | 11.214.666 $ | +5.480.955 $ | +81,4 % | 3 | ||||